Evidence map›Paper›PMID 40981273›Full record

ArticleAntibodies (Basel, Switzerland)2025

Structure-Guided Stapling of Dimeric Conformations and Linker Engineering Enhance Thermostability and Fine-Tune Activity of Bispecific VHH Cytokine Agonists.

Raphael Trenker, Deepti Rokkam, Andrew Morin, Priyanka Balasubrahmanyam, Verenice Paredes, Ivan Cheng, Rene de Waal Malefyt, Martin Oft, Patrick Lupardus, Sandro Vivona

Abstract read
In one paragraph

Article in Antibodies (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Raphael TrenkerDepartment of Discovery, Pharmacology and Translational Research, Synthekine, Menlo Park, CA 94025, USA.ORCID 0000-0003-1748-0517
Deepti RokkamDepartment of Discovery, Pharmacology and Translational Research, Synthekine, Menlo Park, CA 94025, USA.
Andrew MorinDepartment of Discovery, Pharmacology and Translational Research, Synthekine, Menlo Park, CA 94025, USA.
Priyanka BalasubrahmanyamDepartment of Discovery, Pharmacology and Translational Research, Synthekine, Menlo Park, CA 94025, USA.
Verenice ParedesDepartment of Discovery, Pharmacology and Translational Research, Synthekine, Menlo Park, CA 94025, USA.ORCID 0000-0002-0267-0230
Ivan ChengDepartment of Discovery, Pharmacology and Translational Research, Synthekine, Menlo Park, CA 94025, USA.
Rene de Waal MalefytDepartment of Discovery, Pharmacology and Translational Research, Synthekine, Menlo Park, CA 94025, USA.ORCID 0000-0002-2663-383X
Martin OftDepartment of Discovery, Pharmacology and Translational Research, Synthekine, Menlo Park, CA 94025, USA.
Patrick LupardusDepartment of Discovery, Pharmacology and Translational Research, Synthekine, Menlo Park, CA 94025, USA.
Sandro VivonaDepartment of Discovery, Pharmacology and Translational Research, Synthekine, Menlo Park, CA 94025, USA.ORCID 0000-0003-2340-3219

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBispecific antibodies have emerged as a promising class of therapeutics, enabling simultaneous targeting of two distinct antigens. Single-domain antibodies (sdAbs) comprising camelid variable heavy chains (VHHs) provide a compact and adaptable platform for bispecific antibody design due to their small size and ease of linkage.

methodsHere we investigate structure-activity relationship of VHH-based cytokine surrogates by combining cell signaling and functional assays with x-ray crystallography and other biophysical techniques.

resultsWe describe crystal structures of four unique bispecific VHHs that engage and activate the cytokine receptor pairs IL-18Rα/IL-18Rβ and IL-2Rβ/IL-2Rγ. These bispecific VHH molecules, referred to as surrogate cytokine agonists (SCAs), create unique cytokine signals that can be tuned by linker engineering. Our structural analysis reveals multiple dimeric conformations for these bispecific SCAs, where the two VHH domains can interact to form a compact structure. We demonstrate that the dimeric conformation can be enforced via engineering of a non-native disulfide bond between the VHH subunits, thus enhancing molecular thermostability.

conclusionOur findings have important implications for the design and engineering of bispecific VHHs or sdAbs, offering a novel strategy for tuning their activity and increasing their stability.

Indexed as

bispecific nanobodycytokine surrogate agonistdevelopabilitydisulfide staplingIL-18IL-2immunotherapysingle-domain antibodythermostabilityVHH

Identifiers

PMID40981273
PMCPMC12452691

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.